A New Treatment for Amyotrophic Lateral Sclerosis Gets Approved, but Trial Results Are Spotty
source: pixabay.com

A New Treatment for Amyotrophic Lateral Sclerosis Gets Approved, but Trial Results Are Spotty

According to a story from CNN, a new treatment was recently approved by the US Food and Drug Administration (FDA) for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's…

Continue Reading A New Treatment for Amyotrophic Lateral Sclerosis Gets Approved, but Trial Results Are Spotty
Ifenprodil for IPF Earns Orphan Drug Designation
Sourced from: James Heilman, MD / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

Ifenprodil for IPF Earns Orphan Drug Designation

In the United States, Orphan Drug designation is granted to drugs or biologics intended to treat, diagnose, or prevent rare diseases or conditions. These are defined as conditions affecting fewer…

Continue Reading Ifenprodil for IPF Earns Orphan Drug Designation